Extraordinary Future Conference 2018: Notes from the Floor – Part II

The second annual Extraordinary Future Conference wrapped up on Thursday (September 20) in Vancouver with panel discussions and presentations revolving around cannabis, eSports and cleantech.  On the second and final day of the show, the event hosted by Cambridge House showcased over 70 companies exhibiting their products and company presentations in addtion panel discussions. The conference “Deal Room” was also buzzing with  companies, experts and analysts in talks with  interested investors in these verticals. The Investing News Network (INN) was once again at the event covering panel dicussions and conducting inteviews. If you missed the show, here’s a wrap up of day two of the event. For more on what happened on the first day of the show, click here. Canopy up 2,200% in 2 years! Don’t miss out on more cannabis investment opportunities Give me my free report! The first talks of the day were cannabis-related with Robert Laurie, a lawyer well-versed in … Continue reading

Tilray’s Wild Ride Continues with 18 Percent Stock Dip

Investors of Canadian licensed producer (LP) Tilray (NASDAQ:TLRY) were thrown for a rollercoaster ride during Thursday’s (September 20) trading session as the company dropped almost 18 percent. Shares of the cannabis company finished the day at a price of US$176.35, representing a dip of 17.62 percent from its previous closing price. During after hours trading the stock had seen an additional drop of 2.18 percent. Tilray stock had been on an unprecedented rush path in the public markets for a cannabis stock. Over the past month shares of the company grew 435.95 percent in value, with the stock reaching a 52-week high of US$300 price per share. Canopy up 2,200% in 2 years! Don’t miss out on more cannabis investment opportunities Give me my free report! Tilray’s share price outgrew its estimations according to research data from analysts on TipRanks. The current price target for the company is US$34 on … Continue reading

Beleave Announces 867,000 Square Feet of New Indoor Growing Capacity in B.C.

Beleave Inc. (CSE:BE) (OTCQX: BLEVF) (“Beleave” or the “Company”) is excited to announce that is has entered into a partnership with Kannavis Biotech Corp. (“Kannavis”) to invest, build and operate 867,000 square feet of indoor growing space in British Columbia in preparation for the anticipated demand for cannabis in the Canadian and International marketplace. The ambitious new project, jointly-designed by Beleave and Kannavis, will encompass a total of ten indoor growing facilities, approximately 87,000 square feet each, divided between two regions; one in Chilliwack, and nine in Abbotsford. Once construction is complete, both companies will share the operational and day-to-day expenses, with Kannavis assuming sole responsibility for the initial capital expenditures required to build the facilities. Phase one of the development will begin with the construction of two facilities, one in each city, and is already underway. Both facilities are expected to be completed in mid-2019, with an annual projected capacity of 13,500 kg … Continue reading

Agrima Botanicals Corp. Develops Methodology for Water-Soluble Cannabinoid Delivery

Ascent Industries (CSE:ASNT) (“Ascent” or the “Company”) is pleased to announce that through its wholly-owned subsidiary, Agrima Botanicals Corp., the Company has developed a proprietary methodology for producing a variety of discrete, water-soluble cannabinoids, both in powder and liquid form. Cannabinoids in their natural state are oil-based and non-water soluble, making it challenging for beverage makers and edibles manufacturers to evenly suspend and standardize their product mixtures. Water-soluble cannabinoids emulsify evenly, allowing both beverage and edibles makers to completely standardize their product mixtures, giving end consumers a consistent, high quality product experience. Additionally, water-soluble cannabinoids have a faster activation time of approximately 10-15 minutes in the human body, compared to 30-45 minutes generally for oil-based delivery methods. These effects generally wear off within two hours compared to 4-6 hours with traditional oil-based products. This development strengthens the Company’s intellectual property footprint, providing the potential for Ascent to become a leading provider of cannabinoid formulates.  … Continue reading

Kalytera Therapeutics Provides Update for Lead Program in Prevention and Treatment of GVHD

Kalytera Therapeutics, Inc. (TSXV:KALY, OTCQB:KALTF) (the “Company” or “Kalytera”) today provided an update on its lead product development program evaluating cannabidiol (“CBD”) for the prevention and treatment of acute graft versus host disease (“GVHD”). GVHD is a life-threatening complication commonly occurring after bone marrow transplant procedures. GVHD occurs when the transplanted donor cells attack the patient’s organs, including the skin, GI tract, liver, lungs, and eyes. GVHD is associated with acute and chronic illness, infections, disability, reduced quality of life, and death. It is estimated that up to 50% of patients who undergo a bone marrow transplant from a sibling donor, and up to 70% of patients who undergo a bone marrow transplant from an unrelated donor, will develop some level of GVHD. There are currently no FDA approved therapies for either the prevention or treatment of acute GVHD. CBD is a non-psychotropic ingredient of cannabis that does not cause … Continue reading

FSD Pharma Inc. Announces $7.5 Million Dollar at $1 Per Share Investment as Part of Existing Strategic Alliance with Auxly Cannabis Group Inc.

FSD Pharma Inc, (CSE:HUGE) is pleased to announce that pursuant to the approved construction and development budget announced on July 3, 2018 (Link), Auxly Cannabis Group Inc. (TSXV – XLY) (“Auxly”) has made an equity investment into the Company at $1.00 per Class B Subordinate Voting Share for total proceeds of $7.5 million. No fees were paid to brokers in connection with the transaction. All of the securities issued in connection with the Offering are subject to a hold period expiring on January 20, 2019. Proceeds of the financing will be deployed toward construction of the 220,000 square foot cultivation footprint that FSD and Auxly are jointly developing pursuant to their strategic alliance and streaming agreement previously announced on March 5, 2018 (the “Joint Cultivation Footprint”) (Link). The buildout of the Joint Cultivation Footprint is currently underway in Cobourg, Ontario and will include dedicated space for large scale extraction capabilities. In addition to the Joint Cultivation Footprint, FSD is also … Continue reading

Redfund Capital Partners With US Based Plant Life Cannabis Fertilizer Leader

Redfund Capital Corporation (CSE:LOAN) (Redfund or the “Company”) is pleased to announce that it is now the Canadian resident agent for US cannabis fertilizer leader Plant Life. Plant Life is dedicated to offering professional cannabis growers a superior line of fertilizers formulated to create a strong holistic growing environment, with a philosophical and authentic mindset towards plant health, a truly preventative approach, verses curative, resulting in better yields and better value. It manufactures both liquid and dry water-soluble fertilizers designed to enhance each phase of a plant’s growth cycle, maximize growers’ yields and increase potency. The products are produced and fully loaded with superior macro, secondary and micronutrient ingredients to ensure optimum nutrient availability and reduced waste. Plant Life recognizes the artistry that growers bring to the table. The quality supplements were designed to give them the tools to boost their yields from root augmentation through final stages of the flower. … Continue reading

Canntab Sets New All-Time High Trading Prices and Volume

Canntab Therapeutics (CSE:PILL) (“Canntab” or the “Company”), a leader in the development of the cannabis in tablet or capsule form, is pleased to announce that the Company’s common shares (“Common Shares”) yesterday reached new all-time daily high and closing prices of $1.74 and $1.41, respectively, on the Canadian Securities Exchange (the “CSE”). These numbers exceed the Company’s previous all-time highs by 39.2% and 15.6%, which were also set earlier this week. In addition, the Company traded an aggregate of 1,583,326 Common Shares yesterday at a total dollar value of $2.06M, which constitutes its all-time high daily volume and exceeds the Company’s previous highs, set on the Company’s opening day of trading on April 20, 2018. “We are thrilled that the investment community is taking notice of the positive developments occurring at Canntab. Our team has been focusing its efforts on developing the core business, and our dedication is being rewarded … Continue reading

BLOK Technologies Signs MOU with Visionary Private Equity Group to Form Proposed Joint Venture for the Development of Blockchain Applications for the Real Estate Industry

BLOK Technologies Inc. (CSE:BLK) (FRANKFURT:2AD) (“BLOK Tech” or the “Company”) is pleased to announce that Visionary Private Equity Group (“VPEG”) and the Company have entered into a non-binding Memorandum of Understanding (“MOU”) to form a joint venture for the development of technology for the real estate industry. Under the terms of the MOU, which is subject to the parties agreeing upon definitive terms, BLOK Tech will license its Greenstream blockchain technology platform in exchange for a US $500,000 licensing fee and a 25% equity position in a to-be formed joint venture company (“NewCo”). The MOU outlines the terms of the proposed strategic partnership between VPEG and BLOK Tech relating to the development of new technology enterprises, the first of which is expected to be with a real estate company partner. “This is a significant milestone for BLOK Technologies,” said Rob Dawson, CEO of BLOK Tech. “Our business model has always … Continue reading

Key Cannabis Players Launch Venture Capital Companies

Investors will gain two new options in the public cannabis space this week, and they’re backed by two of the biggest Canadian cannabis companies out there. Canopy Rivers, a division of Canadian licensed producer behemoth Canopy Growth (NYSE:CGC,TSX:WEED), is expected to launch on Thursday (September 20), while Australis (CSE:AUSA), a spinoff of Aurora Cannabis (TSX:ACB), listed on Wednesday (September 19). Canopy Rivers will trade under the ticker symbol “RIV” on the TSX Venture Exchange, while Australis is on the Canadian Securities Exchange under the ticker symbol “AUSA.” Looking for Cannabis Stocks? Read our report to find market data, important news and stocks to watch! Give me my free report! The debut of these two stocks represents a move from leading cannabis producers to seek additional entry points in the space: investment in technologies and businesses within the cannabis market. These venture capital companies will monitor the space and seek businesses worthy of investment. A … Continue reading